Custom Search


Login
MY ACCOUNT
support_button
Not a customer? Click Here
Video
Today's Health Headlines
U.S. hog farmers are ramping up safety procedures and leaving animal-feed ingredients imported from China in storage in an attempt to keep out a highly contagious swine disease that is sweeping through Asia and Europe.

Marlboro cigarette maker Philip Morris International drew accusations of hypocrisy on Monday after using a four-page newspaper advertisement to urge smokers to quit cigarettes.

China's three-month old outbreak of African swine fever has spread for the first time to the country's south, its major pork-consuming region, signaling how deeply the deadly disease has permeated the country's pig herd, the world's largest.

Roche's Tecentriq plus chemotherapy boosted lung cancer patients' survival by nearly five months, study data released on Monday showed, underscoring benefits of the Swiss group's immunotherapy but still leaving it trailing a rival's drug.

Chinese authorities are probing a local unit of global catering giant Compass Group Plc over mouldy and expired food found at a private school served by the group and said it would inspect other schools around the city.

German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.

An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.

Roche's entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area.

An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.

An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation.

ADVERTISEMENT